Aspen Aerogels (ASPN) news
Recent news
Barclays raises target price to $5 from $4 for Aspen Aerogels Inc.
AInvest Wire · Aug 11, 2026Aspen Aerogels European thermal barrier outlook FY revenue USD 20-30 million (adds dropped words "European thermal barrier", removes reference to estimates)
Aspen Aerogels, Inc. (NYSE: ASPN) has outlined a financial outlook for its European thermal barrier segment, projecting full-year 2026 revenue in the range of USD 20-30 million. This forecast reflects the company’s strategic focus on expanding its presence in the European market, supported by…
AInvest Wire · Aug 6, 2026Aspen Aerogels Q2 revenue USD 49.849 million vs. IBES estimate USD 42.4 million
Aspen Aerogels, Inc. (NYSE: ASPN) reported second-quarter 2026 revenue of $49.849 million, surpassing the IBES estimate of $42.4 million. The company’s performance reflects a strategic focus on operational resilience and market diversification amid ongoing challenges. The company’s Q2 2026 revenue…
AInvest Wire · Aug 6, 2026Aspen Aerogels Q2 adjusted EPS USD -0.22 vs. IBES estimate USD -0.21
AInvest Wire · Aug 6, 2026Aspen Aerogels outlook Q3 net loss per share $0.07 to $0.11
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.